Plant Comparison

Tea vs Coffee (Arabica & Robusta)

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant ATeaCamellia sinensisTheaceaeFull monograph →
Plant BCoffee (Arabica & Robusta)Coffea arabicaRubiaceaeFull monograph →

At a glance

Tea and Coffee (Arabica & Robusta): they share 4 indicated uses (cardiovascular / heart health, cognitive function, memory, …); 2 pharmacological actions in common.

TeaCoffee (Arabica & Robusta)
Constituents33
Pharmacological actions62
Indicated uses114
Safety notes22
Cited sources2118
Indicated uses
Only Tea
Arthritis / joint painBlood sugar / diabetes supportCancer (anticancer research)Infection (general)Inflammation (general)Skin irritationWounds
Shared (4)
Cardiovascular / heart healthCognitive functionMemoryMetabolic support
Only Coffee (Arabica & Robusta)
none
Pharmacological actions
Only Tea
Anti-inflammatoryAnticancer (preclinical)Antidiabetic (blood-sugar lowering)Antimicrobial
Shared (2)
AntioxidantNeuroprotective / cognition support
Only Coffee (Arabica & Robusta)
none

Evidence face-off — shared uses

ConditionTeaCoffee (Arabica & Robusta)Verdict
Cardiovascular / heart health1/109/10Stronger for Coffee (Arabica & Robusta)
Cognitive function1/109/10Stronger for Coffee (Arabica & Robusta)
Memory1/109/10Stronger for Coffee (Arabica & Robusta)
Metabolic support1/109/10Stronger for Coffee (Arabica & Robusta)

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Catechins (EGCG, ECG) and polyphenols[1, 15]

Principal antioxidant polyphenols, most concentrated in minimally oxidised green tea; epigallocatechin gallate (EGCG) is the best studied.

CatechinsPhenolic compounds
Caffeine and theanine[1]

Caffeine gives tea its mild stimulant effect; L-theanine, a unique amino acid, is associated with calm alertness and modulates caffeine's effects.

Caffeine
Theaflavins and thearubigins[15]

Oxidative polymerisation products of catechins formed during black tea processing, contributing to black tea's colour and its own antioxidant profile.

Caffeine[1]

The principal stimulant alkaloid, driving alertness and much of coffee's pharmacological activity.

Caffeine
Chlorogenic acids[1]

Major antioxidant polyphenols of the green and roasted bean, linked to metabolic and hypoglycaemic effects.

Chlorogenic acidPhenolic acids
Diterpenes (cafestol, kahweol)

Present in unfiltered coffee (e.g. French press, espresso); raise LDL cholesterol, unlike paper-filtered coffee where they are largely removed.

Pharmacological Actions

Anti-inflammatory[15]
Anticancer (preclinical)[4, 5, 9, 15]
Antidiabetic (blood-sugar lowering)[15]
Antimicrobial[8, 11, 12, 15]
Antioxidant[4, 6, 10, 15]
Neuroprotective / cognition support[6, 15]
Antioxidant[1, 3, 5, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17]
Neuroprotective / cognition support[2, 9, 10, 11, 12, 13, 14, 15, 16, 17]

Traditional & Indicated Uses

Arthritis / joint pain[15]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Blood sugar / diabetes support[15, 17]Traditional · 1/10

inferred from antidiabetic action

Evidence: 1
Label: Blood sugar / diabetes support
Cancer (anticancer research)[5, 9]Good · 8/10

inferred from anticancer action

Evidence: 8
Label: Cancer (anticancer research)
Cardiovascular / heart health[15, 17]Traditional · 1/10
Evidence: 1
Label: Cardiovascular / heart health
Cognitive function[15, 18]Traditional · 1/10

inferred from neuroprotective action

Evidence: 1
Label: Cognitive function
Infection (general)[15]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Infection (general)
Inflammation (general)[15]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Memory[15, 18]Traditional · 1/10

inferred from neuroprotective action

Evidence: 1
Label: Memory
Metabolic support[15, 17]Traditional · 1/10
Evidence: 1
Label: Metabolic support
Skin irritation[15]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Wounds[15]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Wounds
Cardiovascular / heart health[6, 9, 10, 11, 12, 13, 14, 15, 16, 17]Strong · 9/10
Evidence: 9
Label: Cardiovascular / heart health
Cognitive function[9, 10, 11, 12, 13, 14, 15, 16, 17]Strong · 9/10

inferred from neuroprotective action

Evidence: 9
Label: Cognitive function
Memory[9, 10, 11, 12, 13, 14, 15, 16, 17]Strong · 9/10

inferred from neuroprotective action

Evidence: 9
Label: Memory
Metabolic support[1, 9, 10, 11, 12, 13, 14, 15, 16, 17]Strong · 9/10
Evidence: 9
Label: Metabolic support

Safety, Cautions & Contraindications

Safety note[15, 17, 18]Serious

Generally safe in moderate consumption. High caffeine intake may cause insomnia, anxiety, palpitations, or dependence. Large amounts of green tea extract supplements may be hepatotoxic (rare). May reduce iron absorption if consumed with meals. Avoid very high supplement doses during pregnancy.

Safety note[15, 17, 18, 19]Caution

Duke (2002) rates tea (Camellia sinensis) as ++ and notes anti-aggregant, antioxidant, anticariogenic, and antibacterial activities at the experimental level (score 1). The catechins (EGCG, ECG) and polyphenols are responsible for the antioxidant and anticancer properties under research investigation. Duke notes that green tea preserves more polyphenols than black tea due to less oxidation. Regular tea consumption is associated with reduced cardiovascular risk. Excess consumption (>10 cups daily) may cause fluoride-related bone changes. Caffeine content is relevant for sleep disturbance, anxiety, and interactions with cardiovascular medications (Duke, 2002).

Safety note[9, 10, 11, 12, 13, 14, 15, 16, 17]Caution

Caffeine is the primary psychoactive component; excessive intake (>400 mg/day in adults, >200 mg/day in pregnancy) can cause anxiety, insomnia, palpitations, and elevated blood pressure. Caffeine dependence and withdrawal (headaches, fatigue) are well documented. Individuals with anxiety disorders, arrhythmias, or hypertension should limit intake. Cafestol and kahweol in unfiltered coffee (e.g., French press, espresso) raise LDL cholesterol; paper-filtered coffee removes these compounds. During pregnancy, limit to <200 mg caffeine/day due to risk of foetal growth restriction. Coffee may interact with certain medications including thyroid hormones, levothyroxine, and some antibiotics (ciprofloxacin increases caffeine levels). Heartburn and gastro-oesophageal reflux are common side effects in sensitive individuals (EFSA, 2015; NIH, 2023).

Safety note[9, 10, 11, 12, 13, 14, 15, 16, 17, 18]Caution

Duke (2002) notes clinical evidence (score 2) for coffee as an adsorbent (activated charcoal use), astringent, bronchodilator, and gastric stimulant. A key safety concern: unfiltered (e.g., French press or boiled) coffee raises LDL cholesterol (hypercholesterolemic effect, score 2) due to diterpenes cafestol and kahweol. Filtered coffee does not carry this risk. Duke notes coffee's CNS stimulant, diuretic, and hepatoprotective properties, though excessive consumption is associated with increased anxiety, tachycardia, and hypertension. It is contraindicated in peptic ulcer disease due to gastric acid stimulation (Duke, 2002).

External Ids

Gbif: 3189635
Wikidata: Q101815
Gbif: 2895345
Powo: urn:lsid:ipni.org:names:747038-1
Wikidata: Q47685

Botanical Description

Evergreen shrub or small tree with glossy, dark green, leathery, finely toothed leaves. Small, fragrant, white flowers with a prominent central boss of yellow stamens are borne singly or in small clusters in the leaf axils. Commercial tea is made from the young leaves and unopened leaf buds ('sprouts'), processed differently to yield green, black, white or oolong tea from the same species.[15]

Height: 1-9 m (kept pruned to 1-1.5 m under cultivation)
Habit: Evergreen shrub or small tree, usually kept pruned as a shrub
Leaves: Glossy, dark green, leathery, finely toothed
Flowers: Small, fragrant, white, with a prominent boss of yellow stamens
Stem: Woody, branching, evergreen
Root: Deep taproot
Fruit: Woody capsule containing a few large seeds
Flowering Period: Autumn to winter

Evergreen shrub or small tree with glossy, dark green, oval leaves in opposite pairs. Small, fragrant, white, star-shaped flowers cluster along the branches, followed by clusters of green berries ('cherries') that ripen to red and each contain two flattened seeds - the coffee beans.[1]

Height: Up to 5-10 m in the wild (kept pruned to 2-3 m under cultivation)
Habit: Evergreen shrub or small tree, usually pruned lower in cultivation
Leaves: Glossy, dark green, oval, in opposite pairs
Flowers: Small, fragrant, white, star-shaped, clustered along the branches
Stem: Woody, branching
Root: Deep taproot with fibrous lateral roots
Fruit: Fleshy berry ('cherry') ripening green to red, containing two flattened seeds (coffee beans)
Flowering Period: Varies with climate; often after the rainy season

Habitat

Native to the subtropical and tropical forests and hillsides of East and South Asia (China, India, Myanmar); cultivated extensively across Asia, Africa and elsewhere on well-drained, acidic upland soils.[15]

Native to the highland forests of Ethiopia and South Sudan; cultivated across the tropical highland belt worldwide (Latin America, Africa, Asia) at elevation, on well-drained, often volcanic soils.

Harvesting

The youngest leaves and unopened leaf buds ('flush') are hand- or machine-picked repeatedly through the growing season; how the fresh leaf is subsequently processed (withered, rolled, oxidised, fixed and dried) determines whether it becomes green, black, white or oolong tea.[15]

Parts: Leaf, Young sprouts
Season: Repeated flushes through the growing season

Ripe red berries are hand- or machine-picked, then processed (washed or dried) to remove the fruit pulp and expose the two seeds ('beans'), which are dried, hulled and roasted before use.

Parts: Seed

Traditional Uses

Tea has an ancient East Asian tradition as both a beverage and a medicinal tonic, used for alertness, digestion and general wellbeing; green tea in particular has a long-standing reputation, now widely studied, as an antioxidant, cardiometabolic and cognitive-support beverage.[1, 15]

Coffee has a centuries-long tradition, originating in Ethiopia and spreading through the Arab world and beyond, as a stimulant beverage taken for alertness and to counter fatigue; its seed and leaf extracts have more recently been studied for antioxidant, metabolic and neuroprotective properties.[1]

Preparations

Infusion (green tea)[15]

Young leaf, minimally oxidised, infused in hot water; the least-processed and most-studied form for antioxidant polyphenol content.

Standardised extract[15]

Concentrated leaf extract standardised to catechin (e.g. EGCG) content, taken as capsules; used in some clinical studies, though high-dose extracts carry rare hepatotoxicity concerns.

Standardised extract[1]

Decaffeinated or standardised green/roasted bean or leaf extract, taken as capsules for antioxidant or metabolic support studies.

Dosage

Infusion[16]

The EU herbal monograph on green tea leaf (Camelliae sinensis non fermentatum folium) gives, for adults and elderly, 1.8-2.2 g of the whole or comminuted leaf in 100-150 mL of boiling water as an infusion, 3-5 times daily; a powdered herbal substance at 390 mg three times daily (up to 5 if necessary) is also listed. Contraindicated in gastric and duodenal ulcers, cardiovascular disorders such as hypertension and arrhythmia, and hyperthyroidism. Not recommended under 18 years. Educational reference only, not a prescription.

Brewed coffee[9]

The EFSA Scientific Opinion on the safety of caffeine concluded that habitual caffeine intakes up to about 400 mg daily (roughly 3-4 cups of brewed coffee) do not raise safety concerns for healthy adults, and that single doses up to 200 mg are likewise not of concern. For pregnant women EFSA sets a lower figure of up to 200 mg per day. Note this is a safe-intake ceiling for caffeine, not a therapeutic dose of coffee. Educational reference only, not a prescription.

References

REF-0755, REF-0756, REF-0757, REF-1960, REF-1961, REF-1962, REF-1963, REF-1964, REF-1965, REF-1966, REF-1967, REF-1968, REF-1969, REF-1970
REF-2379, REF-2380, REF-2381, REF-2382, REF-2383, REF-2384, REF-2385, REF-2386

Drug Class Interactions

Safety note[20, 21]Caution
Drug Class: antihypertensives
Mechanism: Green tea catechins block an intestinal uptake transporter (OATP1A2) that some blood-pressure medicines rely on for absorption. In a controlled study, drinking green tea cut blood levels of the beta-blocker nadolol by about 85% and blunted its blood-pressure-lowering effect. If you take nadolol (or other OATP-transported medicines), separate green tea from the dose by several hours and keep intake consistent; watch that your blood pressure stays controlled.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03

Not documented

Lookalikes Review

Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

References & Sources

  1. Mancini, E., Beglinger, C., Drewe, J., Zanchi, D. et al (2017) 'Green tea effects on cognition, mood and human brain function: A systematic review', Phytomedicine, 34, pp. 26-37. doi:10.1016/j.phymed.2017.07.008 Meta-analysis / review
    https://doi.org/10.1016/j.phymed.2017.07.008
  2. Musial, C., Kuban-Jankowska, A. and Gorska-Ponikowska, M (2020) 'Beneficial Properties of Green Tea Catechins', International Journal of Molecular Sciences, 21(5), pp. 1744. doi:10.3390/ijms21051744 Traditional / reference
    https://doi.org/10.3390/ijms21051744
  3. Ohishi, T., Goto, S., Monira, P., Isemura, M. and Nakamura, Y (2016) 'Anti-inflammatory Action of Green Tea', Anti-inflammatory & Anti-allergy Agents in Medicinal Chemistry, 15(2), pp. 74-90. doi:10.2174/1871523015666160915154443 Traditional / reference
    https://doi.org/10.2174/1871523015666160915154443
  4. Zhao, T., Li, C., Wang, S. and Song, X (2022) 'Green Tea (Camellia sinensis): A Review of Its Phytochemistry, Pharmacology, and Toxicology', Molecules, 27(12), pp. 3909. doi:10.3390/molecules27123909 Meta-analysis / review
    https://doi.org/10.3390/molecules27123909
  5. Filippini, T., Malavolti, M., Borrelli, F., Izzo, A.A., Fairweather-Tait, S.J., Horneber, M. and Vinceti, M (2020) 'Green tea (Camellia sinensis) for the prevention of cancer', Cochrane Database of Systematic Reviews, 3(3), pp. CD005004. doi:10.1002/14651858.CD005004.pub3 Meta-analysis / review
    https://doi.org/10.1002/14651858.CD005004.pub3
  6. Prasanth, M.I., Sivamaruthi, B.S., Chaiyasut, C. and Tencomnao, T (2019) 'A Review of the Role of Green Tea (Camellia sinensis) in Antiphotoaging, Stress Resistance, Neuroprotection, and Autophagy', Nutrients, 11(2), pp. 474. doi:10.3390/nu11020474 Meta-analysis / review
    https://doi.org/10.3390/nu11020474
  7. Bedrood, Z., Rameshrad, M. and Hosseinzadeh, H (2018) 'Toxicological effects of Camellia sinensis (green tea): A review', Phytotherapy Research, 32(7), pp. 1163-1180. doi:10.1002/ptr.6063 Meta-analysis / review
    https://doi.org/10.1002/ptr.6063
  8. Hamilton-Miller, J.M.T (2001) 'Anti-cariogenic properties of tea (Camellia sinensis)', Journal of Medical Microbiology, 50(4), pp. 299-302. doi:10.1099/0022-1317-50-4-299 Meta-analysis / review
    https://doi.org/10.1099/0022-1317-50-4-299
  9. Conde, V.R., Alves, M.G., Oliveira, P.F. and Silva, B.M (2015) 'Tea (Camellia sinensis (L.)): a putative anticancer agent in bladder carcinoma?', Anti-Cancer Agents in Medicinal Chemistry, 15(1), pp. 26-36. doi:10.2174/1566524014666141203143143 Meta-analysis / review
    https://doi.org/10.2174/1566524014666141203143143
  10. Moore, R.J., Jackson, K.G. and Minihane, A.M (2009) 'Green tea (Camellia sinensis) catechins and vascular function', British Journal of Nutrition, 102(12), pp. 1790-1802. doi:10.1017/S0007114509991218 Meta-analysis / review
    https://doi.org/10.1017/S0007114509991218
  11. Gaur, R. and Bao, G.H (2021) 'Chemistry and Pharmacology of Natural Catechins from Camellia sinensis as Anti-MRSA Agents', Current Topics in Medicinal Chemistry, 21(17), pp. 1519-1537. doi:10.2174/1568026621666210524100632 Meta-analysis / review
    https://doi.org/10.2174/1568026621666210524100632
  12. Tafazoli, A. and Tafazoli Moghadam, E (2020) 'Camellia Sinensis Mouthwashes in Oral Care: a Systematic Review', Journal of Dentistry (Shiraz), 21(4), pp. 249-262. doi:10.30476/DENTJODS.2020.83204.1045 Meta-analysis / review
    https://doi.org/10.30476/DENTJODS.2020.83204.1045
  13. Albassam, A.A. and Markowitz, J.S (2017) 'An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis)', Planta Medica, 83(6), pp. 496-508. doi:10.1055/s-0043-100934 Meta-analysis / review
    https://doi.org/10.1055/s-0043-100934
  14. Gramza-Michalowska, A (2014) 'Caffeine in tea Camellia sinensis - content, absorption, benefits and risks of consumption', Journal of Nutrition, Health & Aging, 18(2), pp. 143-149. doi:10.1007/s12603-013-0404-1 Meta-analysis / review
    https://doi.org/10.1007/s12603-013-0404-1
  15. Chacko, S.M. et al (2010) 'Beneficial effects of green tea: a literature review'. Traditional / reference
    https://scholar.google.com/scholar?q=Beneficial%20effects%20of%20green%20tea%3A%20a%20literature%20review
  16. European Medicines Agency (HMPC) (2013) 'Community herbal monograph on Camellia sinensis (L.) Kuntze, non fermentatum folium'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-camellia-sinensis-l-kuntze-non-fermentatum-folium_en.pdf Traditional / reference
    https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-camellia-sinensis-l-kuntze-non-fermentatum-folium_en.pdf
  17. Drake, V.J (2015) 'Tea catechins and cardiovascular disease risk', 74(1), pp. 39--46. Traditional / reference
    https://scholar.google.com/scholar?q=Tea%20catechins%20and%20cardiovascular%20disease%20risk
  18. Nobre, A.C., Rao, A. and Owen, G.N (2008) 'L-theanine, a natural constituent in tea, and its effect on mental state', pp. 167--168. Traditional / reference
    https://scholar.google.com/scholar?q=L-theanine%2C%20a%20natural%20constituent%20in%20tea%2C%20and%20its%20effect%20on%20mental%20state
  19. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
  20. Misaka, S., Yatabe, J., Muller, F., Takano, K., Kawabe, K., Glaeser, H., Yatabe, M.S., Onoue, S., Werba, J.P., Watanabe, H., Yamada, S., Fromm, M.F. and Kimura, J (2014) 'Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects', Clinical Pharmacology and Therapeutics, 95(4), pp. 432-438. doi:10.1038/clpt.2013.241 Randomized trial
    https://doi.org/10.1038/clpt.2013.241
  21. Werba, J.P., Misaka, S., Giroli, M.G., Shimomura, K., Amato, M., Simonelli, N., Vigo, L. and Tremoli, E (2018) 'Update of green tea interactions with cardiovascular drugs and putative mechanisms', Journal of Food and Drug Analysis, 26(2S), pp. S72-S77. doi:10.1016/j.jfda.2018.01.008 Meta-analysis / review
    https://doi.org/10.1016/j.jfda.2018.01.008
  1. Nascimento, G.O. and Marques, S.P.D. and Maia, C.E.G. and de Sousa, A.F. and Cunha, R.L. and Malta, M.R. and Owen, R.W. and Ferreira, M.K.A. and da Silva, A.W. and Reboucas, E.L. and de Menezes, J.E.S.A. and Marinho, M.M. and Marinho, E.S. and Dos Santos, H.S. and Saliba, A.S.M.C. and Massarioli, A.P. and Alencar, S.M. and Sartori, A.G.O. and Trevisan, M.T.S (2023) 'Hypoglycemic effect of Coffea arabica leaf extracts and major bioactive constituents', Journal of Biomolecular Structure & Dynamics, 41(24), pp. 14871-14886. doi:10.1080/07391102.2023.2188421 Preclinical
    https://doi.org/10.1080/07391102.2023.2188421
  2. Malakar, V.K. and Roy, D. and Malakar, C.C. and Khetmalis, Y.M. and Mali, P.C. and Poddar, N.K (2025) 'Targeting IDO1 in Huntington's Disease: Network Pharmacology and Preclinical Evidence from Coffea arabica', Neurochemical Research, 50(1), pp. 263. doi:10.1007/s11064-025-04509-5 Preclinical
    https://doi.org/10.1007/s11064-025-04509-5
  3. Ruse, G. and Jijie, A.R. and Moaca, E.A. and Patrascu, D. and Ardelean, F. and Jojic, A.A. and Ardelean, S. and Tchiakpe-Antal, D.S (2025) 'Coffea arabica: An Emerging Active Ingredient in Dermato-Cosmetic Applications', Pharmaceuticals, 18(2), pp. 171. doi:10.3390/ph18020171 Meta-analysis / review
    https://doi.org/10.3390/ph18020171
  4. Matosinhos, R.C. and Bezerra, J.P. and Barros, C.H. and Fernandes Pereira Ferreira Bernardes, A.C. and Coelho, G.B. and Carolina de Paula Michel Araujo, M. and Dian de Oliveira Aguiar Soares, R. and Sachs, D. and Saude-Guimaraes, D.A (2021) 'Coffea arabica extracts and their chemical constituents in a murine model of gouty arthritis: How they modulate pain and inflammation', Journal of Ethnopharmacology, 284, pp. 114778. doi:10.1016/j.jep.2021.114778 Preclinical
    https://doi.org/10.1016/j.jep.2021.114778
  5. Chang, Q.X. and Lyu, J.L. and Wu, P.Y. and Wen, K.C. and Chang, C.C. and Chiang, H.M (2023) 'Coffea arabica Extract Attenuates Atopic Dermatitis-like Skin Lesions by Regulating NLRP3 Inflammasome Expression and Skin Barrier Functions', International Journal of Molecular Sciences, 24(15), pp. 12367. doi:10.3390/ijms241512367 Preclinical
    https://doi.org/10.3390/ijms241512367
  6. Hutachok, N. and Angkasith, P. and Chumpun, C. and Fucharoen, S. and Mackie, I.J. and Porter, J.B. and Srichairatanakool, S (2020) 'Anti-Platelet Aggregation and Anti-Cyclooxygenase Activities for a Range of Coffee Extracts (Coffea arabica)', Molecules, 26(1), pp. 10. doi:10.3390/molecules26010010 Preclinical
    https://doi.org/10.3390/molecules26010010
  7. Capek, P. and Paulovicova, E. and Matulova, M. and Mislovicova, D. and Navarini, L. and Suggi-Liverani, F (2014) 'Coffea arabica instant coffee - chemical view and immunomodulating properties', Carbohydrate Polymers, 103, pp. 418-426. doi:10.1016/j.carbpol.2013.12.068 Preclinical
    https://doi.org/10.1016/j.carbpol.2013.12.068
  8. Cangeloni, L. and Bonechi, C. and Leone, G. and Consumi, M. and Andreassi, M. and Magnani, A. and Rossi, C. and Tamasi, G (2022) 'Characterization of Extracts of Coffee Leaves (Coffea arabica L.) by Spectroscopic and Chromatographic/Spectrometric Techniques', Foods, 11(16), pp. 2495. doi:10.3390/foods11162495 Preclinical
    https://doi.org/10.3390/foods11162495
  9. European Food Safety Authority (2015) 'Scientific Opinion on the safety of caffeine', 13(5). doi:10.2903/j.efsa.2015.4102 Traditional / reference
    https://doi.org/10.2903/j.efsa.2015.4102
  10. Ding, M., Bhupathiraju, S.N., Satija, A., van Dam, R.M. and Hu, F.B (2014) 'Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies', 129(6), pp. 643--659. doi:10.1161/CIRCULATIONAHA.113.005925 Meta-analysis / review
    https://doi.org/10.1161/CIRCULATIONAHA.113.005925
  11. Goldstein, E.R., Ziegenfuss, T., Kalman, D. et al (2010) 'International society of sports nutrition position stand: caffeine and performance', 7(1), pp. 5. doi:10.1186/1550-2783-7-5 Traditional / reference
    https://doi.org/10.1186/1550-2783-7-5
  12. Higdon, J.V. and Frei, B (2006) 'Coffee and health: a review of recent human research', 46(2), pp. 101--123. doi:10.1080/10408390500400009 Clinical study
    https://doi.org/10.1080/10408390500400009
  13. International Coffee Organization (2023) 'Coffee Report & Outlook 2023'. Available at: https://icocoffee.org Traditional / reference
    https://icocoffee.org
  14. Kennedy, O.J., Roderick, P., Buchanan, R. et al (2016) 'Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis', 43(5), pp. 562--574. doi:10.1111/apt.13523 Meta-analysis / review
    https://doi.org/10.1111/apt.13523
  15. National Institutes of Health (2023) 'Caffeine'. Available at: https://medlineplus.gov/caffeine.html Traditional / reference
    https://medlineplus.gov/caffeine.html
  16. Ross, G.W., Abbott, R.D., Petrovitch, H. et al (2000) 'Association of coffee and caffeine intake with the risk of Parkinson disease', 283(20), pp. 2674--2679. doi:10.1001/jama.283.20.2674 Clinical study
    https://doi.org/10.1001/jama.283.20.2674
  17. Royal Botanic Gardens, Kew (n.d.) 'Coffea arabica L'. Available at: https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:320737-2 Traditional / reference
    https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:320737-2
  18. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.